European Journal of Cancer 2012-01-01

Simvastatin plus capecitabine–cisplatin versus placebo plus capecitabine–cisplatin in patients with previously untreated advanced gastric cancer: A double-blind randomised phase 3 study

Seung Tae Kim, Jung Hun Kang, Jeeyun Lee, Se Hoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim, In Gyu Hwang, Sang-Cheol Lee, Keon-Woo Park, Hyo Rak Lee, Won Ki Kang

Index: Eur. J. Cancer 50(16) , 2822-30, (2014)

Full Text: HTML

Abstract

Purpose We aimed to the addition of synthetic 3-hydroxy-3-methyglutaryl coenzyme A (HMG-CoA) reductase inhibitor, simvastatin to capecitabine–cisplatin (XP) in patients with previously untreated advanced gastric cancer (AGC).

Related Compounds

  • Simvastatin
  • Fluorouracil
  • 2'-Deoxycytidine m...

Related Articles:

Environmental friendly method for urban wastewater monitoring of micropollutants defined in the Directive 2013/39/EU and Decision 2015/495/EU.

2015-10-30

[J. Chromatogr. A. 1418 , 140-9, (2015)]

Oxysterols synergize with statins by inhibiting SREBP-2 in ovarian cancer cells.

2014-11-01

[Gynecol. Oncol. 135(2) , 333-41, (2014)]

Autocrine secretion of 15d-PGJ2 mediates simvastatin-induced apoptotic burst in human metastatic melanoma cells.

2014-12-01

[Br. J. Pharmacol. 171(24) , 5708-27, (2014)]

Endothelial protective genes induced by statin are mimicked by ERK5 activation as triggered by a drug combination of FTI-277 and GGTI-298.

2015-07-01

[Biochim. Biophys. Acta 1850 , 1415-25, (2015)]

Statin treatment affects cytokine release and phagocytic activity in primary cultured microglia through two separable mechanisms.

2014-01-01

[Mol. Brain 7 , 85, (2015)]

More Articles...